MBA Students 2028

Born in Karachi, raised in Dublin, and most recently based in London, I have a background in Chemical Engineering and Computational Chemistry. At Pfizer and GSK, I’ve worked at the intersection of AI and biopharma, driving manufacturing and R&D productivity to lower biologics costs and expand global patient access. Previously, I founded a VTOL venture (passenger drones), securing $25M in signed LOIs and Innovate UK funding.

I grew up in Austin, Texas, and attended UT Austin graduating with dual degrees in Finance and Business Honors. I joined Accenture Strategy out of a desire to learn across industries and problems, and found myself drawn to healthcare and life sciences wanting to improve the lives of patients through my work.

I’ve worked across the commercial lifecycle of life sciences companies, from evaluating portfolio divestiture decisions for corporate venture arms to building market access and commercialization strategies for biotech clients. I moved into op model and org design, helping clients build governance and organizational capabilities across functions like R&D, field sales, and supply chain to ensure their organizations can scale alongside their science.

Beyond client work, I lead my practice’s life science task force, building learning and development programming and co-led the Women’s Initiative platform.

I am the Founder and CEO of Advantis, a New York City-based population health company focused on improving healthcare engagement among underserved Medicaid and Medicare populations. Through partnerships across New York state, my team conducts proactive outreach to members, identifies health-related social needs, and connects individuals with the resources and services necessary to improve health outcomes and reduce the possibility of developing illnesses.

My career began at J.P. Morgan in 2023 as a biotech equity research analyst, where I was analyzing small-cap biotech companies focused on small molecule therapeutics, but I quickly transitioned to the healthcare investment banking team at the firm. My time on the team further bolstered my interest in being an operator and owner. It also forced me to understand how business mechanics differed in healthcare compared to other industries. After contemplating for some time, I left my role after two years and went back to working on the healthcare company I founded during my senior year of college. Ultimately, verbal agreements that led me to my decision went cold, and I found myself forced to pivot several times over the next year. Our current strategy revolves around the thesis that addressing social determinants of health early can prevent the progression of chronic disease, reduce unnecessary utilization, and improve quality of life.

Today, Advantis serves as a partner within New York’s value-based care ecosystem, identifying hard-to-reach Medicaid members, helping them overcome barriers to care, and connecting them with the appropriate clinical and community-based resources. While the company is still in its early stages, I believe engagement is one of the most underappreciated challenges in healthcare. My long-term vision is to build Advantis into a comprehensive population health company that not only addresses social needs but also supports preventive care, chronic disease management, and other value-based care initiatives that improve outcomes while reducing the overall cost of care.

I also served in the Army National Guard throughout undergrad and 3 years postgrad. I left the forces as a Sergeant.

I grew up academically at Penn. I studied economics here as an undergrad, and after a few years away I’m back for round three. In between, I did research at the NIH, went to medical school at Brown, trained in internal medicine at NYU, and spent a year doing clinical research at Mass General Brigham. I just wrapped up my allergy & immunology fellowship at Penn Medicine, so feel free to ask me about your seasonal allergies (everyone does).

I’ve also caught the startup bug twice. In med school, I co-founded CPR Connect, a startup that aimed to improve bystander CPR rates. The startup didn’t survive despite intensive resuscitation efforts, but I learned a lot through the experience. Now I’m founding Immune Strata, a diagnostics company I’m building at Penn with the Department of Dermatology, based on my postdoctoral research developing microneedle patches for allergy testing. I also work with OpenEvidence as part of its clinician network, helping shape how AI evolves in clinical medicine.

I first became interested in the intersection of healthcare and technology during my undergraduate studies in Public Health, where I started thinking about how we can use technology to tackle some of the system’s most complex and expensive challenges.

After graduating, I decided to explore Digital Health by joining Relevant–a bootstrapped, mission-driven startup. Being part of a small team taught me how to build healthcare products thoughtfully in a resource-constrained environment, without abandoning our company’s core mission to support primary care in under-resourced communities.

I later brought those experiences to Tempus AI, where I’ve continued to grow as a Product Manager and sharpen my product instincts in a more scaled, data-driven setting.

I grew up in Rehoboth Beach, Delaware, where my parents owned their own private medical practice. From an early age, I saw how differently the system can look on paper than it feels for patients and providers. I went to Penn expecting to follow my parents into medicine, but over time realized I was less drawn to clinical practice and more interested in the systems behind healthcare access, affordability, and care delivery. That led me to major in Neuroscience and Economics and to conduct research on price transparency in primary care.

After graduating, I spent nearly three years in life sciences strategy consulting at Accenture, working with pharmaceutical clients on market access, drug commercialization/launch, and patient access strategy. Working on those projects sparked my interest in the broader payer and policy decisions that drive affordability, such as how care gets reimbursed, how access is structured, and how incentives shape what patients actually experience. This led me to apply to and join the dual MPP/MBA program at HKS and Wharton, where I’m focused on health policy and management.

I just finished my first year of the dual degree program in May 2026. This summer, I’m working at MassHealth (Massachusetts’ Medicaid agency), where I’ve gotten to see a lot of these payer-side questions from inside a state agency, first on enrollment and access for Medicaid members receiving home- and community-based care, and now on cost growth and fiscal sustainability for the managed care population. At Wharton, I hope to build on this experience to continue learning more about the healthcare system and how it can be redesigned to improve access and affordability.

I grew up in a small town in Northern New Jersey and spent my senior year in Geneva, Switzerland, where I graduated high school. I went on to earn a Bachelor of Science in Mechanical Engineering from Villanova University, with a minor in Engineering Entrepreneurship. At Villanova, I was also a member of the Women’s D1 Rowing team.

After graduation, I joined Deloitte Consulting in New York City, where I had the opportunity to focus on deepening my experience in Life Sciences, Healthcare, and Strategy. My work has been primarily focused on supporting global pharmaceutical companies across Commercial, Pricing & Access and Supply Chain with their operating model strategy, strategic transformations, program implementation and brand strategy work. Through this work, I’ve become especially excited by the LSHC industry and the opportunity to help organizations navigate innovation in today’s readily changing environment.

As a practicing physician who trained in New York City during the COVID-19 pandemic, I have honed the ability to interpret rapidly-changing information and lead multidisciplinary teams to take excellent care of critically ill patients. In my time working in public, private, and federally-run hospital systems, I have witnessed examples of effective healthcare delivery, as well as many areas ripe for improvement. I am keenly aware of which systems, drugs, devices, and technologies provide value to providers and patients, and which do not. I look forward to leveraging my physician background and MBA education to partner with physician-founders, healthcare executives, and investors to innovate within the healthcare system at scale.

I grew up in Lincolnwood, IL and studied Finance and Accounting at UIUC. After starting my career at PwC and earning my CPA, I joined J.P. Morgan’s M&A team and later moved to Vistria, where I did healthcare private equity investing.

I started my career at McKinsey and am currently an Engagement Manager within our Healthcare practice. I was drawn to complex problems with sometimes difficult trade-offs, and worked across various industries and topics (e.g., citizen experience for federal entities, operating model design for philanthropies, economic development strategy for states) before finding my way to healthcare work.

Within healthcare, I’ve served clients across academic medical centers, payers, pharmaceutical companies, and healthcare services entities, and gained a deep appreciation for the complexities in the ecosystem. A lot of my work has been focused on medication access, patient experience, operational excellence, and innovation.

In addition to client work, I support the Firm’s Learning & Development mission as a master faculty, completed a rotation as a Fellow at McKinsey Global Institute (our economics think tank) focused on sustainable, inclusive growth, and have been a part of 4 international offices.

I grew up in Manhattan Beach, CA (a suburb of Los Angeles) and went to Stanford University for undergrad. At Stanford, I majored in Human Biology with a concentration in the Economics of Healthcare Policy and minored in African and African American Studies.

Following my time at Stanford, I spent 2 years working as a business consultant in the Transformation, Design & Execution practice at Ernst & Young’s (EY) San Francisco office. I coordinated quarterly business demos and program increment planning events that allowed our Fortune 500 client to increase collaboration across their workstreams and business stakeholders.

With this industry experience under my belt, I then moved to Philadelphia to attend the Perelman School of Medicine (PSOM). At PSOM, I coordinated two student-run clinics offering affordable health care to queer, African and Afro-Caribbean communities around Philadelphia. I am currently in my 4th year of Penn’s MD/MBA program.

I grew up in upstate New York and attended Williams College, where I majored in Economics and Political Science. After graduating, I moved to Boston and later worked as a Consultant at Health Advances, a life sciences strategy firm. My earliest engagements focused on GTM strategy for digital health and health tech companies, and that exposure inspired me to pursue a role at Biofourmis, a digital health startup. At Biofourmis, I managed marketing and digital strategy across BiofourmisCare for health systems and BiofourmisConnect for biopharma partners. After two fulfilling years, I joined eqBridge, a boutique life sciences commercialization consultancy, as Head of Marketing and Program Management. In this role, I built upon my marketing experience by shaping the firm’s marketing strategy while expanding into biopharma commercialization through launch-focused engagements across rare disease and oncology.

I grew up in the Boston area before attending Pomona College where I studied Economics. After graduating, I joined Bain & Company, splitting my time between the Los Angeles and Boston offices. At Bain, I focused primarily on private equity due diligence and supported strategy work for a major healthcare payer – helping them think through how to deliver the most effective care for every dollar spent, while preserving access and improving outcomes for their population.

I grew up in California with my parents and older brother. As an adolescent I was interested in art and channeling my creativity, but through volunteer work and research I developed a passion for healthcare and technology. While I initially planned to pursue medicine, my experiences at one of UC Davis’s student-run clinics serving a rural farming community shifted my interest toward improving healthcare at the systems level.
After graduating, I joined Charles River Associates’ Life Sciences practice, where I explored the business and economics of healthcare through strategy consulting. Two years later, I transitioned to Rightway, a healthcare technology company, where I now work as a Client Success Manager partnering with employers while collaborating closely with Product and Engineering teams to improve healthcare affordability and the member experience.

I grew up in New England, having called Vermont, New Hampshire, and Massachusetts home. I attended the United States Air Force Academy for undergraduate studies and commissioned into the Space Force, where I held several roles across Operations, Logistics, and Acquisitions. I am motivated to continue serving others by transitioning into the healthcare space, helping emerging and innovative companies scale while developing people through empathetic leadership. I’m excited to continue developing my foundation of service-oriented principles by adding value to an industry that works to continuously make the world a better place.

I joined Sanofi on their Aspiring Leaders Graduate Programme, and in just under five years, I’ve had five different roles across the business. The first three were within the UKIE affiliate, where I gained broad commercial experience across immunology, respiratory, cardiovascular, and diabetes.

Last year, I moved to Paris to sit within the Global Insulins Brand Team, where I collaborated with global markets at different stages of the product lifecycle.

Most recently, as part of our new Global AI-driven Customer Engagement team, I’ve been helping to define how we can integrate AI at scale from a marketing perspective across our key markets, whilst navigating the highly regulated industry.

I grew up just outside of Philadelphia and later studied Chemistry and Economics at Penn. After graduating, I began my career as a consultant at Simon-Kucher, where I worked on projects across the healthcare spectrum, from supporting digital health app monetization to leading development of go-to-market strategies for cell and gene therapies. After 3 years, I transitioned to an equity research role at Wolfe Research, an independent sell-side research firm. Here, I was the lead associate on 10+ pharma and large-cap biotech companies, including Lilly and Biogen. I spent much of my time maintaining our long-term financial models, while also tracking and quantifying how regulatory, clinical, and financial developments reshaped the sector.

I grew up in Texas and became interested in healthcare strategy after seeing how differently people experienced the healthcare system, even within my own family. This interest led me to McKinsey, where I’ve worked on healthcare strategy across providers, payers, and public-sector organizations over the past ~4 years. I also spent 15 months on secondment at Gates Ventures focusing on global women’s health and health equity initiatives. I’m excited to continue building my career focused on making healthcare more accessible and effective for everyone!

I grew up in Princeton, NJ, and studied mechanical engineering at Tufts University for my undergrad. After realizing I did not want to pursue engineering full-time, I began my career in consulting at Accenture where I spent just under four years in the Life Sciences practice. I worked primarily with big pharma commercial teams on projects spanning portfolio strategy, customer engagement models, launch planning, competitive success, and most recently defining best practices for AI-enabled marketing teams.

I’m a first-generation student who studied Electrical Engineering at Unicamp, entering through ProFIS, a selective bridge for public school graduates. I began set on a research career, working across lasers, atomic simulation, control systems, and IoT, before a national scholarship took me to Paris for a Master of Science in Robotics and AI at ENSTA ParisTech.

There I pivoted from research to business, launching my own startup in travel (TripIA) and playing a pivotal role in launching two others (WeFalco and IBM’s Smart Green Pallet). Back in Brazil, I worked on global digital transformations at Braskem before moving into strategy consulting to build my business foundation and broaden my impact. Over the past four years at Strategy& and BCG, I’ve worked across strategy, reorganization, and operations for clients spanning infrastructure, healthcare, animal nutrition, and more.

What ties my path together is a “bench-to-boardroom” range. I’ve crossed from frontier research to high-tech product building to strategy work across more than a dozen industries. It’s taught me to translate sophisticated ideas into decisions that survive board scrutiny and actually get implemented, which is exactly what I want to keep doing as I return to entrepreneurship, bridging technology and business to create real value.

I grew up in Sudbury, Massachusetts and studied Economics at Vanderbilt, later earning my MSF there as well. After graduating, I joined the Healthcare Investment Banking team at Oppenheimer & Co., where I spent four years advising biopharma and medical device companies on M&A and capital raises.

After double majoring in Chemistry and Economics, I pursued a career in economic consulting at Analysis Group, where I focus primarily on healthcare litigation. Alongside this work, I continue to lead the company I founded in college, which helps underprivileged students from Romania and Eastern Europe apply to universities abroad, aiming to democratize access to higher education for a new generation of students.

I spent the first 2 years of my career working as a software engineer at Google Health and Fitbit Research working on consumer health research and data visualization before starting medical school here at Penn.

I grew up in Atlanta, Georgia, before moving to New Hampshire to attend Dartmouth College. There, I studied Politics, Philosophy, and Economics (PPE) while completing the pre-med track. Throughout college, I found myself drawn to both the clinical and business sides of healthcare. These intersecting interests ultimately led me to pursue healthcare consulting at Trinity Life Sciences in Boston.
Over the past four years, I have worked with a wide range of pharmaceutical and biotech clients, supporting projects across the drug lifecycle – from indication prioritization and pre-launch strategy to brand optimization and commercial due diligence.
Through my time at Trinity, I was exposed firsthand to both the innovation happening in mental healthcare and the many ways our current system still falls short. Those experiences sparked a deeper interest in the space and reinforced my desire to build a career focused on improving mental health outcomes.

I started my professional career as a research technician in an academic lab in Boston designing CAR-T immunotherapies to treat solid tumors.
After recognizing how slow early-stage drug development processes are, I sought to work further downstream where clinical development and market dynamics intersect, which I was able to find in life sciences consulting.
I’ve spent the last 4 years at Trinity Life Sciences in NYC within our Brand & Marketing Strategy team which supports Global commercials teams in executing various strategic planning initiatives.

I grew up in Acton, MA and spent my summers in Ogunquit, ME with my grandparents, where my grandma’s stories of her emergency room nursing career first sparked my curiosity about health care. I attended Cornell University, where I majored in Policy Analysis and Management with a Business minor. As my health policy classes revealed the structural challenges of the health care system, I was further inspired to pursue a health care career.

After graduating, I joined Deloitte’s Strategy practice in NYC, where I delivered market entry strategy, technology & AI strategy, and brand management programs for commercial health care clients spanning health insurance, behavioral health, and retail pharmacy. Through these experiences, I gained exposure across the health care value chain and worked with a wide range of client stakeholders, from strategy and operations leaders to IT and data teams.

In addition to my client work, I led Deloitte’s Health Care Chief Strategy Officer (CSO) program, designing quarterly forums for CSOs to discuss emerging health care topics, such as a clinical AI session co-hosted with Mount Sinai, and publishing insights for Deloitte’s Health Care Strategy blog.

I helped build OCMS Bio, a Philadelphia-area biotech start-up focused on antibody discovery and engineering. Since 2021, I have helped build and lead the organization through early fundraising, platform development, and business growth while advancing a pipeline of next-generation therapeutics.

Prior to entering biotech, I served for five years as an infantry officer in the United States Marine Corps, where I led teams across the spectrum of training and operational environments. I attended Vanderbilt University where I studied Neuroscience and Philosophy.

I grew up in Carmel, Indiana and attended Indiana University, where I studied Finance and Business Analytics. After graduating, I began my career in New York City with Cain Brothers, a healthcare-focused middle market investment bank. While at Cain Brothers, I focused on M&A advisory and capital raising transactions across services, HCIT, life sciences, and medical technology.

After two years, I moved to Chicago and joined Linden Capital Partners, a middle market private equity firm with a healthcare-specific industry focus. While at Linden, I worked extensively with several portfolio companies across consumable medical products, healthcare services, and pharma biospecimen procurement. I helped these portfolio companies pursue strategic M&A, define market and growth strategies, and worked as a trusted partner to the C-Suite across varying projects. I also evaluated new platform opportunities and helped execute an investment in a pharmacy care management company.

I grew up in Prior Lake, Minnesota and attended the University of Pennsylvania, where I studied Economics and Political Science. After college, I joined BCG’s Minneapolis office, where I have spent the past three years in our healthcare provider practice, supporting academic medical centers, specialty care hospitals, and community health systems. Specifically, my work has focused on clinical growth strategy, service line optimization, and end-to-end transformation. Most recently, I have helped a state government design programs to deploy rural health transformation funding.

I grew up in Alaska and South Carolina before attending the University of South Carolina, where I studied Biochemistry & Molecular Biology. During college, I became interested in the innovation side of medicine through wet lab research, studying iron regulation at UofSC and herpesvirus vaccine targets at the NIH. I also developed an interest in delivering sustainable healthcare through global health experiences in South America. After graduating, I worked in hepatology clinical research at Penn Medicine, where I coordinated observational studies of cirrhosis and autoimmune hepatitis, as well as a clinical trial for polycystic liver disease. I stayed in Philly to pursue my MD at Penn and have developed clinical interests in primary care and dermatology.

I was born and raised in Queens, NY before completing my degree in Biomedical Engineering at the University of Michigan in 2020. This is when my interest began in translating medical technology to augment patient care. I then came back to NY to work at the Kenny Lab in Mount Sinai, conducting translational research on opioid addiction.

I started my journey as a medical student at Penn Med in 2023. I have since worked with DOVE (opioid overdose detection and reversal device startup), and conducted research in ECMO and critical care technology where I became highly interested in the ways technology can augment patient care, especially in terms of care transitions. Following this insight, through my MBA I hope to build the operational and leadership skills to improve care transitions and integrate effective innovations into clinical practice during my career as a physician.

I was pre-med as an undergraduate at Harvard, and pursued clinical research in breast oncology post-grad to gain clinical exposure. After a year in Boston, I moved to New York City and began working at Trinity Life Sciences, a life sciences strategy consulting firm.

My four years at Trinity focused on commercial strategy for pharmaceutical and biotech companies across a broad range of therapeutic areas, including oncology, immunology and neurology. I worked primarily on opportunity assessments for pre-commercial assets and portfolio strategy projects.

I was born and raised in Plano, Texas, though I’ve spent the last nearly ten years living on the East Coast. At Harvard, I studied Human Developmental & Regenerative Biology and Psychology. Outside of the classroom, I developed novel gene editing approaches as a research assistant at the Brigham & Women’s Hospital and reported on the School of Engineering & Applied Sciences for The Harvard Crimson, the student newspaper.

After graduation, I joined ClearView Healthcare Partners as a life sciences strategy consultant, working in both the Boston and New York offices. There, I supported pharmaceutical clients on strategic decisions ranging from multi-billion-dollar company acquisitions to lifecycle management opportunities for early clinical assets. My particular area of focus was new product planning in the oncology space. Guided by learnings from stakeholder interviews, I delivered strategic recommendations for clients on key business questions at the product, portfolio, and company levels.

After graduating from Northwestern University with a degree in Economics and a Master of Science in Integrated Marketing Communications, I began my career at Transparent Partners, a boutique consulting firm focused on helping Fortune 500 consumer brands better activate their data and modernize their marketing technology. There, I focused on developing data strategies, implementing and managing tech platforms like customer data platforms, and building operating models and processes to support them.
During this time, I realized I wanted to build a career more directly connected to improving people’s lives. Around the same time, I was diagnosed with Li-Fraumeni syndrome, a genetic condition that significantly increases my lifetime cancer risk. Navigating the healthcare system firsthand gave me a deeper understanding of the challenges patients face and ultimately inspired me to transition into healthcare.
I then joined GoHealth, an AI-driven marketplace that helps consumers navigate Medicare and the complex health insurance landscape. As the Insights and Reporting lead on the Commercial team, I analyzed the evolving Medicare landscape, informed partnership and product strategy, and identified growth opportunities beyond Medicare Advantage. Through this work, I helped drive commercial performance while improving access to coverage and supporting long-term customer retention.

I was born and raised in Athens, Greece. At 18, I left home to pursue my studies abroad. My mother is from Chicago and my father is Greek, and I always hoped to eventually live and work in the United States. Before making that move, I studied Economics at the University of Sussex in England. During college, internships with Deloitte in Athens introduced me to M&A and sparked my interest in finance. I subsequently earned an MSc in Finance & Economics from the University of Warwick before moving to Chicago, where I spent three years in consumer investment banking before joining Sheridan Capital Partners to focus on healthcare investing. I am excited to continue exploring the intersection of healthcare and finance at Wharton.

I grew up in Chicago, IL and studied Quantitative Social Science at Dartmouth. I first worked as an Investment Banking Analyst in the Global Industrials Group at Citi, where I helped advise appliance manufacturers, multinational mining conglomerates, automotive suppliers, and private equity firms on M&A and capital markets transactions. After two years at Citi, I spent three years at BC Partners as a Private Equity Associate. During my time at BC, I evaluated numerous investment opportunities across the Healthcare Services landscape and worked closely with the management teams of Women’s Care, a large OB/GYN physician network, and PetSmart, the largest pet retailer in the United States. I also served on the deal team that completed the acquisition of PetLab, a leading animal supplement brand.

I grew up in New Jersey and studied biomedical engineering at Duke, where I also researched early autism diagnosis (my younger brother has autism, which is why I’ve always gravitated toward healthcare). After college, I went into consulting, first a short stint at Accenture, then L.E.K., while moonlighting as a patient care technician on weekends to earn clinical hours for medical school. After a year of that, I realized that while I wanted to make an impact in healthcare, I was more interested in the business side, so I dropped the med school plan and stayed in consulting. Over 4.5 years at L.E.K., I worked in the Healthcare Services practice across payer, provider, and HCIT work, completing ~35 cases spanning diligences, operations, and strategy. Two of my most formative cases were behavioral health network strategy for a national payer and post-merger synergy and operations work for an infusion clinic.

I grew up in Northern California before attending Johns Hopkins University, where I studied Molecular & Cellular Biology and Public Health. I’m currently an MD/MBA student at Penn pursuing a career in orthopaedic surgery with interests at the intersection of clinical medicine, healthcare strategy, and physician leadership.

During medical school, I’ve been fortunate to work with mentors across several institutions on research in orthopaedics and health policy. Much of my work has focused on using clinical data to better understand patient outcomes, healthcare utilization, and opportunities to improve the quality and value of musculoskeletal care. Beyond research, I’ve been actively involved in Penn HealthX and other interdisciplinary healthcare innovation and entrepreneurship initiatives.

At Wharton, I’m excited to step outside of medicine, learn from classmates with diverse backgrounds, and explore how business, innovation, and entrepreneurship can help build more effective and patient-centered healthcare systems.

I graduated from Duke with a longstanding passion for medicine and curiosity about its intersection with business. I spent 3 years doing life sciences strategy consulting at ClearView Healthcare Partners before joining GSK. At GSK, I work as a marketing manager for Benlysta (a biologic therapy for lupus).

I was born in London and moved to Virginia when I was in first grade. I’m proud to be both Korean and Romanian, and I grew up alongside my twin sister and younger brother. I’ve been interested in science since high school, where I conducted a two-year research project focused on deterring an invasive species of fruit fly using a combination of peppermint and thyme essential oils. An internship at Brigham and Women’s Hospital further strengthened my scientific curiosity and sparked what became a lasting passion for healthcare.

I entered Dartmouth with two primary academic interests: Biology and Economics. While I explored a wide range of subjects, those interests remained constant. I pursued healthcare consulting as the best way to combine them. For the past three years, I’ve worked at Putnam in New York City, advising pharmaceutical companies on a range of strategic challenges across commercialization, growth strategy, and due diligence engagements.

At Putnam, much of my work has focused on innovative therapies and emerging areas within life sciences, giving me exposure to both the scientific and strategic considerations that shape business decision-making. While I’ve greatly enjoyed my time in consulting, I’m coming to Wharton to deepen my understanding of the financial side of business decisions within the life sciences space.

I was born and raised in Frankfurt, Germany, and have long been fascinated by the ways our inner lives shape the realities we perceive and move through. This curiosity led me to study Psychology at Harvard through an interdisciplinary lens, drawing on biology, business, and government. There, I became increasingly attuned to how health shapes lived experience, and to how systems often simplify the complexity of being human.

Training as an EMT during the pandemic made these questions more immediate, while navigating the health system as a patient myself gave them personal weight. These experiences deepened my interest in the economic and structural realities of healthcare. After graduating college, that interest ultimately brought me to BCG’s Los Angeles office three years ago, where I have focused on healthcare private equity, MedTech, and pharmaceuticals.

I spent eight years as an officer in the Israeli Navy, following in the footsteps of my father, with my younger brother later joining us in the same uniform.
I commanded combat teams at sea before moving to Navy Headquarters, where I led operational planning and joint operations.

Later, as Operations Manager at the Israeli Consulate General in New York, I coordinated high-profile diplomatic visits, including the Israeli President’s visit to the United Nations.
Living and working in New York sparked my interest in innovation and inspired me to pursue a career at the intersection of healthcare, technology, and leadership.

After being called back to Israel when the October 7 war broke out, I returned to Navy Headquarters before joining TechsoMed as a Product Specialist.
At TechsoMed, I helped deploy an AI-powered imaging platform that enables physicians to perform minimally invasive cancer treatments, working alongside clinical teams at leading hospitals across the U.S. and Europe.

Different uniform, same mission: helping great teams improve patient care through innovation.

I grew up on Long Island in NY and attended Princeton University, earning a degree in Molecular Biology. Foundational experiences in lab research and internships at Regeneron and Amgen drew me into management consulting for life sciences companies; I joined McKinsey & Company in 2022 where I’ve advised Pharma and MedTech clients on programmatic M&A, commercial strategy, and organizational transformation.

Growing up in Toronto, I found my earliest inspiration in my older sister. She was the first in our family to attend college and eventually become a physician. I chose to pursue higher education as well, attending UPenn with majors in Finance and Management. I then joined PIMCO in New York, where I led investment due diligence for private banks and wealth management firms invested across many industries, including healthcare.

Seeking to understand value creation from an operational perspective, I pivoted to Zocdoc’s Commercial Operations & Strategy team, where I focused on sales strategy and go-to-market operations for digital health products leveraged by providers across the platform. From there, I joined Stellar Health’s Customer Success / Strategic Operations team to sharpen my knowledge of value-based care, and the payer-provider ecosystem. I led partnerships with payers and health systems to implement value-based care incentive programs for providers, ultimately improving care outcomes for tens of thousands of patients.

I grew up in Bethesda, Maryland and then attended UVA’s McIntire School of Commerce, where I studied business and psychology. After graduating, I joined Accenture’s Strategy practice in DC, where I’ve spent the past six years partnering with regional and national health plans, health systems, and academic medical centers on a range of projects, including growth strategy, digital transformation, and operating model redesign, with the aim of delivering integrated, patient-centered, high-quality care.

Growing up with two physician parents inspired me to pursue a career in healthcare. After graduating from Cornell University where I studied Operations Research and Information Engineering, I spent the first three years of my career in value-based care improving the lives of Medicaid and Medicare patients at Cityblock Health. During the company’s series C and D growth phases, I worked across operations and data roles to drive patient engagement, lower utilization, and launch and scale new markets.

Building on my experience scaling innovative healthcare models at a startup, I was eager to tackle the operational complexity of a renowned academic medical center that has cared for much of my family. At Memorial Sloan Kettering Cancer Center, I led data-driven strategy initiatives for Patient Access Services, improving patient access, optimizing capacity, and streamlining care delivery from screening through treatment.

I grew up in Irvine, California with plans to become a doctor before attending UC Berkeley, where I studied data science and economics. I began my career at EY as a Technology Risk Consultant, working primarily with fintech companies to help them navigate financial risk in an increasingly digital working world. During my three years at EY, I felt drawn to more purpose-driven work in the healthcare industry, and joined Senior Care Action Network (SCAN) and worked in corporate development, securing partnerships and evaluating M&A opportunities on behalf of a nonprofit Medicare Advantage plan and its five specialty groups providing healthcare to seniors.

I grew up in Manhattan and went to Brandeis University where I majored in History and Business. Upon graduation I moved back to NYC to join Stifel’s healthcare group as an investment banking analyst. After two years of banking I made the jump to Consonance Capital Partners, a middle market private equity firm, where I’ve been for three years now.

While at the Consonance I’ve focused primarily on majority buyouts of cash-flow-positive healthcare services businesses and have had meaningful exposure to a handful of industries (including but not limited to specialty pharmacy, senior care services businesses, medtech device reprocessors, urgent care chains, behavioral health platforms, etc.)

I grew up in Baxter, MN and attended the University of Notre Dame, where I majored in Finance & Political Science. Following undergrad, I started my career in investment banking on the Food, Consumer & Retail team at BMO Capital Markets in Chicago, focusing on M&A and debt financings. Following that, I moved to J.P. Morgan and worked as an analyst on the M&A team, advising on mergers & acquisitions across Energy, Consumer & Retail, Industrials, and Healthcare.

In 2023, I joined Cressey & Company, a middle-market private equity firm focused exclusively on healthcare services and information technology businesses. While at Cressey, I worked across 5 portfolio companies, supporting strategic initiatives and driving add-on M&A execution. I also evaluated new investment opportunities, and executed new investments in ProgenyHealth (provider of infant and maternal health solutions) and Heartbeat Health (provider of cardiac diagnostic testing and virtual care).

I’m originally from the Florida panhandle and attended the University of Florida, where I studied Finance while completing a pre-med curriculum. During my time there, I developed a strong interest in healthcare access and affordability, which led me to pursue an MPH at the Yale School of Public Health before joining Deloitte’s Life Sciences & Health Care Consulting practice.

Over the past five years, I’ve advised life sciences companies on commercial technology strategy and M&A execution. Three of those years were spent embedded in the commercial technology organization of a global biopharma company supporting the end-to-end planning and execution of its $20B spin-off.

Outside of client work, I’m particularly interested in genetics and biotechnology innovation. In college, I competed in a global synthetic biology competition, and more recently, I’ve supported Deloitte’s NextGen Therapies practice by developing educational programs focused on advanced therapies.

At UC Berkeley, I completed a dual degree in Cell Biology and Business Administration through the Robinson Program, giving me both a scientific foundation in drug development and a business lens for thinking about what comes after. Alongside my coursework, I conducted research on coronavirus antivirals, which gave me firsthand exposure to the complex path from discovery to clinical development.

That experience sparked a deeper curiosity about how treatments ultimately reach patients, which led me to join Accenture’s strategy practice. Over several years, I primarily focused on launch strategy for new treatments (e.g., target patient population identification, value chain analysis, evidence generation planning). More recently, my work shifted toward examining where and how AI can transform the way pharmaceutical companies operate, whether rethinking marketing and sales processes, designing new innovation-focused business units, or identifying where automation can drive efficiency across R&D.

I grew up in Houston and attended Northwestern University, where I worked in the Athletics Department before graduating with a degree in Economics. After graduation, I joined Deloitte’s healthcare practice, where I’ve spent the past few years partnering with health systems to improve operational performance and the patient experience through revenue cycle transformation, technology strategy, and enterprise-wide process improvement. Working alongside provider executives has reinforced my passion for building more efficient healthcare organizations that better serve patients. Long term, I hope to help health systems improve both financial sustainability and patient outcomes through thoughtful operational transformation and the strategic adoption of technology.

I grew up in the city of San Francisco, CA and went to Washington University in St. Louis for undergrad where I studied Chemistry and Computer Science. After graduating in 2021, I joined Close Concerns, a San Francisco-based healthcare organization focused on metabolic disease, where I helped inform over 10,000 physicians, scientists, and industry leaders each day on clinical, scientific, regulatory, and commercial developments in diabetes and obesity. At Close Concerns, I primarily covered companies developing medical technologies for people with diabetes, and also completed a brief externship at Biolinq, a Series C-funded continuous glucose monitoring startup, where I worked in corporate development on competitive intelligence and intellectual property strategy.

My two years at Close Concerns gave me a real appreciation for how much happens between scientific discovery and a patient actually benefiting from it, and this tension is a big part of what drew me to medicine. I moved to Philly in 2023 to begin my MD at Penn, and have developed clinical interests in anesthesiology, cardiology, and critical care. At Penn, I’ve also had the chance to work with the Penn Medicine-Wharton Fund for Health on early-stage healthcare investing for disadvantaged communities in Philadelphia, and also conduct research at the Center for Health Care Transformation and Innovation on the use of machine learning to optimize surgical scheduling at Penn Medicine.

I hail from Tampa, FL and went on to study Medical Anthropology at Princeton University culminating in a senior thesis about the impact of climate change on health and livelihood in Cameroon. Directly following undergrad I began medical school at Perelman School of Medicine. During my first summer, I served as a consult in a social determinants of health accelerator internship for a startup focused on improving Black women’s health via intergenerational community and my interest in pursuing an MBA to tangibly make the changes I want to see in global health was piqued.

I grew up in Phoenix and studied biochemistry and global health at Arizona State University. Throughout college, I volunteered with nonprofits focused on international healthcare and cultural exchange. I went straight into medical school at the Perelman School of Medicine at Penn in 2023. There, I became deeply involved in a student-run community clinic, managing its budget and writing grants, and I’ve also done ENT clinical work in the Philippines, where I saw how care delivery and disease processes are governed by the resources around them. My goal is to combine my clinical practice in ENT with academic and community work that improves quality, efficiency, and value for patients.

I was born and raised in the Boston suburbs. I attended Yale University where I majored in Humanities while completing pre-medical coursework. In college, I worked for two summers in the lab at Accent Therapeutics, a now clinical-stage biotech developing small molecule drugs for cancer. Following graduation, I moved to Cambridge, MA and worked as a life science strategy consultant for Clarion Healthcare, which was acquired by Lumanity. I contributed to projects across the drug development and commercialization life cycle, including launch planning for a now blockbuster pediatric vaccine, for small biotech through large pharma clients.

I started medical school at the Perelman School of Medicine in 2023 where I have cared for patients, built clinical knowledge, and continued to support and pursue healthcare innovation. I have conducted research on drug regulation at FDA and worked with the Orphan Disease Center on natural history studies to facilitate future clinical trials in rare diseases. For PennHealthX, I co-led our innovation fund, which provides grants to student healthcare ventures.

I was born in Maryland and moved to Israel with my family at the age of 10. I began my career as a strategy consultant at Monitor Deloitte, advising the Ministry of Health, hospitals, and pharmaceutical companies across Israel. I later served as Chief of Staff for Deloitte Israel’s Life Sciences & Healthcare practice, where I helped advance the Deloitte–Sheba collaboration to establish hospital innovation centers globally. Most recently, I started HealthSci, through which I advise hospitals, HMOs, and healthcare innovators on strategy, commercialization, and innovation. I hold a double bachelor’s degree in Biology and Business from the Hebrew University of Jerusalem.

Before Wharton, I spent five years as a Project Leader at Boston Consulting Group, advising leading biopharma and biotech clients on commercial strategy (for example, shaping the launch strategy for a novel therapy for cardiovascular diseases).

Prior to BCG, I worked in patient-facing roles across dermatology and neurology, where I gained hands-on exposure to surgical practice, clinical trials, and digital health technologies.

After graduating from Duke, I started my career at Bain & Company in the Atlanta office. At Bain, I’ve worked across industries / functions but have spent the majority of my time in the Healthcare Private Equity practice, conducting commercial due diligence and post-acquisition strategy work on assets across healthcare IT, provider / provider services, and life sciences. During my third year at Bain, I also spent five months as an extern at Diana Health, an early-stage maternal healthcare startup. I worked under their Chief of Staff on a variety of special projects covering clinical recruiting, patient engagement, and service line expansion.

I grew up in the Northeast and graduated from the Kelley School of Business at Indiana University with a double major in Accounting and Finance. After graduation, I joined Humana, where I worked across actuarial and Medicare trend functions, supporting solvency, utilization, and market strategy. I then joined Cano Health’s corporate strategy team for the company’s post Chapter 11 turnaround efforts. During my time at Cano, my work has focused on partnering with management and sponsors on enterprise level clinical, operational, and financial initiatives.

I grew up in Cornwall-on-Hudson, NY and graduated from Cornell University in 2022 with a major in Biology and Society. My first role was as a consultant at Bluestar Bioadvisors, a boutique life sciences firm focused on assessing the market opportunities for early-stage drugs with novel mechanisms of action. I then transitioned to customer success at the health tech startup Turquoise Health. There, I worked with hospitals and health systems to support their use of price transparency data for financial strategy and managed care negotiations.

I’m joining Wharton after five years at Komodo Health, where I worked across customer success and data product strategy. Most recently, I partnered with cross-functional teams to bring healthcare data products to market and help life sciences organizations make decisions using real-world data. Before Komodo, I worked with healthcare consulting clients at Guidepoint. My experiences have sparked a growing interest in the provider side of healthcare and the operational challenges of delivering high-quality, accessible care. I’m excited to learn from classmates with diverse backgrounds and explore new ways to improve healthcare delivery.

I grew up in Virginia and attended college at William & Mary where I studied data science and grew interested in its applications to medicine. After graduation, I moved to Philly to pursue my MD at the Perelman School of Medicine. Throughout medical school, I have had the opportunity to pursue consulting projects with local digital health organizations. Alongside building my clinical knowledge, I have remained focused on the ways technology and AI are shaping patient care and healthcare as a whole.

II was born and raised in Houston, Texas and attended Vanderbilt University where I majored in Neuroscience & Medicine, Health, and Society. After graduating, I moved back to Texas and joined Boston Consulting Group in the Houston office. Throughout my time at BCG, I have primarily worked in the Healthcare Practice Area in Payer and Provider operations and strategy.

Since graduation, I’ve worked at ClearView in the investor and corporate strategy practices to assist with company valuation or opportunity assessments for buy-side and sell-side due diligence. More recently, I have spent time on broader biotech corporate strategy engagements, such as long-term planning or investor narratives.

Though I’ve spent all of my time at ClearView, I’ve worked at both our NYC (2 years) and London offices (1 year) before working remotely in Philadelphia for the past two years.

I grew up in Bloomington, IN and as a child my family spent time living in New York before eventually settling down in Chicago, IL. I attended the University of Notre Dame where I majored in Finance. Following college, I worked at Greenhill & Co., an independent boutique investment bank, where I specialized in cross-border M&A advisory in the energy, aerospace & defense, telecom, and industrials space. I then moved on to join the Healthcare team at GTCR, a private equity firm, where I worked in HCIT, healthcare services, pharma services, and MedTech investments.

Over the past five years, I’ve worked across investment banking, private equity, and portfolio company operations, starting as an investment banking analyst at Harris Williams, investing in healthcare at Summit Partners, and, most recently, partnering with the management team at Solutionreach, a Summit-backed healthcare technology company. I’m energized by identifying attractive investment opportunities and working alongside management teams to execute the operational and strategic initiatives that drive long-term value creation.

I grew up in Manhattan and later attended Vanderbilt University, where I earned my degree in Neuroscience. During my time at Vanderbilt, I got the opportunity to explore the therapeutics landscape from primarily a development perspective, and conducted lab research studying addiction mechanisms. After graduating, I spent ~5 years at ClearView Healthcare Partners, a life sciences strategy consulting firm. I’ve had the chance to work with a variety of large pharma, biotech, and precision medicine companies, along with instiutional investors, to evaluate the commercial and strategic potential of a variety of therapeutic and pharma services companies and assets. Over time, I began to specialize in commercial due diligence / value due diligence on potential acquisitions, working in our firm’s newly founded Investor Center of Excellence

I worked at Brightstar Capital Partners as an Investment Associate for the last two years. Prior to that, I worked as an Investment Banking Analyst and Associate within the Healthcare Group at J.P. Morgan.

Originally from the suburbs of Montreal, Canada, I attended McGill University where I majored in finance and was an athlete on the varsity alpine skiing team. After college, I worked in investment banking at RBC Capital Markets on the Canadian diversified team. While at RBC, I got involved on the advisory board of the Institute for Research in Immunology and Cancer (IRIC) of the
University of Montreal which led me to combine my interest in both therapeutics and finance at Investissement Quebec on their VC life sciences team where we invested in biotech and medtech companies. On a personal note, I was diagnosed with Acute Myeloid Leukemia at 22 years old during my last year at McGill and received a stem cell transplant from a Polish woman four months later. I am lucky to have been in full remission ever since.

I grew up in Baltimore County, MD, and attended Wake Forest University, where I earned a B.S. in Finance with minors in Politics and International Affairs.

Following graduation, I joined Harris Williams in Richmond, VA, as an Investment Banking Analyst in the Healthcare & Life Sciences Group, advising clients on both sell-side and buy-side M&A transactions. I worked with a diverse range of healthcare businesses, from founder-owned companies raising their first institutional capital to larger private equity-backed platforms executing strategic initiatives.

After investment banking, I joined WindRose Health Investors in New York City as an Associate on the investment team, focusing on tech-enabled outsourced healthcare services across the payer, provider, and pharmaceutical sectors. During my time at WindRose, I supported the acquisition of several platform and add-on investments and launched the firm’s AI initiative, leading the implementation of tools and workflows designed to enhance productivity.

I grew up in Raleigh, NC and studied Business Administration at the University of North Carolina, where I was a GLOBE Scholar and spent semesters at Chinese University of Hong Kong and Copenhagen Business School. After graduating from UNC in 2023, I joined Bain & Company in the Atlanta office, working across industries including the Healthcare Private Equity Group. I thoroughly enjoyed learning the dynamics of healthcare at Bain, prompting me to pursue a 5-month externship at Belong Health, a value-based healthcare startup in Philadelphia. In addition to validating my growing passion for healthcare, my experience at Belong emphasized the opportunity to leverage value-based care and new technologies as vehicles for improving patient outcomes in rural areas. I’m extremely excited to continue developing my healthcare foundation and understanding of opportunity areas in value-based care during my time at HCM.

I grew up between the suburbs of Chicago and Seattle and studied Economics and Psychology at Northwestern University. During college, an internship at Abbott Labs sparked my interest in healthcare, and after graduation I joined BCG’s Chicago office, where I’ve spent the past three years focused primarily on the industry. My work has spanned insurers, provider systems, and MedTech companies across topics including operating model redesign, digital transformation, and growth strategy.